Faculty of medicine, Cairo University
Cairo, Al-Manial, Cairo, Egypt, 11451, Egypt
Location status: Recruiting
NCT Number: NCT07375147
Female patients presenting with obstructed defecation syndrome due to anterior rectocele will be screened according to inclusion and exclusion criteria. Eligible patients will undergo clinical assessment and appropriate investigations including defecography. After informed consent, patients will be randomized into two groups: Stapled Transanal rectal resection or Stapled Transvaginal rectal resection. Improvement in obstructed defecation symptoms and postoperative complications will be compared between the two groups.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Cairo, Al-Manial, Cairo, Egypt, 11451, Egypt
Location status: Recruiting
This is a randomized controlled trial aims to compare the clinical outcomes of Stapled Transanal versus Stapled Transvaginal rectal resection in female patients with obstructed defecation syndrome (ODS) caused by anterior rectocele.
Female patients presenting to the outpatient colorectal clinic with symptoms of obstructed defecation syndrome will be screened for eligibility according to predefined inclusion and exclusion criteria. All eligible patients will receive a detailed explanation of the study objectives, procedures, potential benefits, and risks. Written informed consent will be obtained prior to enrollment.
A comprehensive preoperative evaluation will be performed for all participants, including detailed medical history, physical and anorectal examination, and appropriate investigations including defecography to confirm the diagnosis and assess the severity of rectocele.
Enrolled patients will be randomly assigned in a 1:1 ratio into one of two intervention groups. Group A will undergo stapled Transanal rectal resection, while Group B will undergo stapled transvaginal rectal resection. All surgical procedures will be performed by experienced colorectal surgeons.
Primary outcome measures will include improvement in obstructed defecation symptoms as assessed by Cleveland Clinic Constipation (CCC) score. Secondary outcomes will include length of hospital stay, operative time, postoperative pain score, postoperative continence state, Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) and postoperative complications.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients were placed in the lithotomy position. Using the trans-anal approach, rectocele was done using PPH circular staplers. A circular anal dilator (CAD) was inserted into the anus and sutured into position. Three full-thickness prolene 2/0 sutures were positioned at the anterior, left anterior lateral, and right anterior lateral locations, approximately 4 cm above the dentate line. At the posterior aspect, a tongue depressor was placed into the CAD groove to protect the posterior rectal wall. After insertion of the Procedure for Prolapse and Hemorrhoids stapler (PPH stapler) into the rectum with its head open past the proximal suture, PPH stapler was progressively closed. Per vaginal examination was done To make sure the stapler did not include the vagina. The stapler was then fired to complete the anterior rectal resection.
The patient in the lithotomy position. Anal dilatation was performed. A transverse incision was made in the mucocutaneous border of the vaginal introitus; the posterior vaginal wall was dissected and separated from the anterior rectal wall up to the posterior fornix. Dissection was extended laterally to the maximum length of the rectocele. Two Babcock clamps were applied longitudinally to the rectocele, and the stapler was fired to divide the rectocele. Partial thickness stitches were applied over the staple line using vicryl 2/0 suture to reinforce the staple line.
Time frame: Up to 6 months postoperatively
Compare Improvement in obstructed defecation symptoms in both groups using Cleveland Clinic Constipation (CCC) score. CCC score ranges from 0 to 30. Higher scores indicate a worse outcome (more severe obstructed defecation symptoms )
Time frame: During surgery
Compare time of operation between both procedure
Time frame: From date of hospital admission until date of hospital discharge, assessed up to 10 days after surgery
Compare how many days patients stay in hospital in both groups
Time frame: Up to 6 months postoperatively
compare surgical site infection in both groups
Time frame: Up to 6 months postoperatively
Time for wound Healing in both groups
Time frame: Up to 6 months postoperatively
Compare Postoperative bleeding in both groups
Time frame: Up to 6 months postoperatively
Compare post postoperative fecal incontinence in both groups
Time frame: Within 48 hours postoperatively
Compare postoperative urine retention in both groups
Time frame: At day 1 and day 7 postoperatively
Compare Pain intensity measured using Visual Analogue Scale between both groups (Visual Analogue Scale for Pain: ranges from 0 to 10 . Higher scores indicate a worse outcome {greater pain intensity})
Time frame: Up to 6 months postoperatively
Compare sexual function in both groups using Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ- 12). PISQ-12 score ranges from 0 to 48. Higher scores indicate better sexual function
Time frame: Up to 6 months postoperatively
Postoperative anal stenosis will be assessed by digital rectal examination and graded clinically as follows:
Time frame: Up to 6 months postoperatively
Postoperative rectovaginal fistula will be assessed using the following methods:
Contact information is provided by the study sponsor or research team.
Cairo University
Other
Outcomes of Transanal Versus Transvaginal Rectal Resection for Anterior Rectocele: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06117670
Behavior, Digestive System Diseases
Cairo, Egypt
View Trial DetailsNCT06902909
Cystocele, Cystocele, Midline
Seinäjoki, Finland
View Trial DetailsNCT04892108
Defecation Disorder, Digestive System Diseases
Ferrara, Italy
View Trial DetailsNCT06430931
Colorectal Disorders, Cystocele
Amersfoort, Utrecht, Netherlands
View Trial Details